News & Events
September 17, 2019 - September 17, 2019
C-Path and NORD Rare Disease Cures Accelerator Data and Analytics Platform Launch, Tuesday, Sept. 17, Bethesda, MD
C-Path and the National Organization for Rare Disorders® will host a meeting to formally launch development of a new rare disease data and analytics platform. Funded by a cooperative agreement through the U.S. Food and Drug Administration, the goal of the platform is to accelerate the movement of therapies from bench to bedside for rare diseases.
- July 12, 2018
- April 28, 2018
November 6, 2017
Proceedings from Huntington’s Disease Regulatory Science Consortium (HD-RSC) Kick-Off Meeting, Nov. 6-7, 2017On November 6 and 7, 2017, in Silver Spring, MD, Critical Path Institute and CHDI Foundation welcomed participants from the pharmaceutical industry, academia, regulatory agencies, and advocacy groups to a kick-off meeting for the Huntington’s Disease Regulatory Science Consortium (HD-RSC). The meeting objectives were to solicit input from stakeholders on HD-RSC plans and deliverables, and...
September 26, 2017
Hemodynamic Adaptation (HA) Workgroup and Retinopathy of Prematurity (ROP) Workgroup Face-to-Face Meetings at Health CanadaDate: September 26, 2017 Where: Ottawa, Ontario (Can also participate via WebEx) The Hemodynamic Adaptation (HA) Workgroup and the Retinopathy of Prematurity (ROP) Workgroup face-to-face meetings will take place on September 26th, 2017. Thanks to INC’s representative Agnes Klein and her Health Canada colleagues, this workshop will take place at the Health Canada headquarters in Ottawa, Ontario. The HA Workgroup will...